NEWS
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero
Genetic Testing Challenges in Oncology: Unnecessary Testing Identifies BRCA2 VUS in 16-Year-Old Girl
Precision Oncology News and My Gene Counsel have partnered to produce the "Genetic Testing Challenges in Oncology" series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used in cancer...
NewHavenBiz.com: Matloff Revolutionizes Genetic Testing
Ellen Matloff, president and CEO of My Gene Counsel, has been described as an advocate and a visionary for her work in the field of genetic testing. "She's an advocate for patients, for genetic counselors, her team, and her community. She deeply cares for our team,...
Genetic Testing Challenges in Oncology: Assuming All Labs Are Equal Gives False Reassurance of Risk
Precision Oncology News and My Gene Counsel have partnered to produce the "Genetic Testing Challenges in Oncology" series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used in cancer...
MMRF CureCloud Study Launches to Democratize Access to Genomic Data in Multiple Myeloma
In an interview with Targeted Oncology, Hearn Jay Cho, MD, PhD, Chief Medical Officer of MMRF and Associate Professor of Hematology and Medical Oncology at Mount Sinai Hospital Ruttenberg Treatment Center and Irene M. Ghobrial, MD, Director of the Clinical...
MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma
If the goal is to enroll as many people as possible in a precision medicine program, the process has to be easy for patients, regardless of their condition, geographic location, or socioeconomic situation. That is the aim of the Multiple Myeloma Research Foundation's...
Genetic Testing Challenges in Oncology: Lynch Syndrome Patient Has Ovaries, Uterus Removed at Age 22
After seeing multiple members of a family with late-stage cancers at young ages, their oncologist suspected that these malignancies may be due to Lynch syndrome. The hereditary cancer syndrome is known to increase genetic risk for certain types of cancers.
Do Your Genes Place You at High Risk for COVID-19?
In the last six months, the world has learned that the SARS-CoV-2 virus, more commonly known as COVID-19, is contagious, can be deadly, and has become a global pandemic. As of today, more than 8.2 million people have tested positive, and more than 445,000 have died...
Webinar: Germline Insights from NGS Somatic Testing – Clinical Challenges and Controversies
GenomeWeb hosted a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing. This case-based discussion provides an...
Genetic Testing Challenges in Oncology: Missed Mutations Highlight Somatic, Germline Test Difference
A patient with Cowden syndrome developed a neuroendocrine tumor. Cowden syndrome is a hereditary condition that causes non-cancerous tumor-like growths in the skin and mucous membranes. It can also increase the risk for certain cancers, such as melanoma, breast, thyroid…